Seattle Genetics Inc (NASDAQ:SGEN)

65.11
Delayed Data
As of Jun 15
 -0.38 / -0.58%
Today’s Change
45.31
Today|||52-Week Range
69.71
+21.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues108.2M135.3M129.6M140.6M
 
 
 
 
 
Cost of Goods Sold6.9M8.0M7.8M8.7M
 
 
 
 
 
Depreciation And Amortization5.4M6.2M7.9M7.0M
 
 
 
 
 
 
Operating ExpensesGross Income95.8M121.1M113.9M124.9M
 
 
 
 
 
General Expenses155.1M153.3M159.0M218.7M
 
 
 
 
 
Research And Development114.4M113.6M110.5M152.5M
 
 
 
 
 
Total Operating Expenses167.5M167.5M174.6M234.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-59.3M-32.2M-45.0M-93.8M
 
 
 
 
 
Extraordinary Credit0.0078.7M0.000.00
 
 
Extraordinary Charge0.000.00-42.9M0.00
 
 
Other Expenses2.9M2.7M0.00-17.9M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-56.4M50.0M-87.1M-111.7M
 
 
 
 
 
Income Taxes0.000.00-27.9M0.00
 
 
Net Income-56.4M50.0M-59.2M-111.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS142.8M143.4M144.1M152.0M
 
 
 
 
 
Shares To Calculate EPS Diluted142.8M148.1M144.1M152.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39$0.34-$0.41-$0.73
 
 
 
 
 
EPS Diluted-$0.39$0.34-$0.41-$0.73